Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2000;84:e4; doi:10.1136/heart.84.2.e4
Copyright © 2000 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2000;84:e4 ( August )

Electronic pages: Paper

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension D Abrams, I Schulze-Neick, A G Magee

Department of Paediatric Cardiology, Royal Brompton & Harefield NHS Trust, Sydney Street, London SW3 6NP, UK

Correspondence to: Dr Magee email: a.magee{at}rbh.nthames.nhs.uk

Accepted 19 April 2000

Primary pulmonary hypertension is a rare disease of childhood, which carries a poor prognosis. Patients often present with severe exercise limitation, and untreated life expectancy is less than 1 year. Pharmacological intervention is directed towards reduction of the raised pulmonary artery pressure with vasodilator treatment, initially with calcium antagonists, although more recently long term prostacyclin treatment has shown benefit in some patients. Heart-lung transplantation remains an option for children with severe disease refractory to therapeutic treatment.   A 4 year old Bangladeshi girl with dyspnoea, cyanosis, and signs of a low cardiac output, is described. Initial treatment with prostacyclin was gradually reduced, and maintenance treatment with oral sildenafil (Viagra; Pfizer) instituted. At follow up 3 months later, her exercise capacity was greatly improved and she continues to enjoy a good quality of life without obvious side effects. In view of the encouraging initial results, this may become an acceptable adjunct in treating this patient group.


Keywords: primary pulmonary hypertension; sildenafil; prostacyclin


© 2000 by Heart

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Das, A., Xi, L., Kukreja, R. C. (2005). Phosphodiesterase-5 Inhibitor Sildenafil Preconditions Adult Cardiac Myocytes against Necrosis and Apoptosis: ESSENTIAL ROLE OF NITRIC OXIDE SIGNALING. J. Biol. Chem. 280: 12944-12955 [Abstract] [Full Text]  
  • Matot, I., Gozal, Y. (2004). Pulmonary Responses to Selective Phosphodiesterase-5 and Phosphodiesterase-3 Inhibitors. Chest 125: 644-651 [Abstract] [Full Text]  
  • WILKINS, M. R, WHARTON, J. (2001). Progress in, and future prospects for, the treatment of primary pulmonary hypertension. Heart 86: 603-604 [Full Text]  
  • Galiè, N., Torbicki, A. (2001). GENERAL CARDIOLOGY: Pulmonary arterial hypertension: new ideas and perspectives. Heart 85: 475-480 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.